ARCHIVES

RFAs Available

This article is from The Cancer Letter archive.

Vol. 22 No. 08 | February 23, 1996

Download PDF Visit The Full Archive

Related Articles

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

NIH Orders Duke Medical Center To Stop Enrollment In Human Research Studies

May 14, 1999

In Brief: French 10 Years Behind In Treatment Techniques, Rauscher Tells Premier; European Interest Grows

September 26, 1975

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

Cyclamate Committee Finds No Proof Of Carcinogenicity

January 23, 1976